Clinical Manifestations of Hemochromatosis in HFE C282Y Homozygotes Identified by Screening
BACKGROUND: Patients with hemochromatosis may suffer organ damage from iron overload, often with serious clinical consequences.
Saved in:
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2008-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/2008/907356 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832562595074146304 |
---|---|
author | Gordon D McLaren Christine E McLaren Paul C Adams James C Barton David M Reboussin Victor R Gordeuk Ronald T Acton Emily L Harris Mark R Speechley Phyliss Sholinsky Fitzroy W Dawkins Beverly M Snively Thomas M Vogt John H Eckfeldt for the Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators |
author_facet | Gordon D McLaren Christine E McLaren Paul C Adams James C Barton David M Reboussin Victor R Gordeuk Ronald T Acton Emily L Harris Mark R Speechley Phyliss Sholinsky Fitzroy W Dawkins Beverly M Snively Thomas M Vogt John H Eckfeldt for the Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators |
author_sort | Gordon D McLaren |
collection | DOAJ |
description | BACKGROUND: Patients with hemochromatosis may suffer organ damage from iron overload, often with serious clinical consequences. |
format | Article |
id | doaj-art-3c6c7556d4464ce498ebe6998618e4c6 |
institution | Kabale University |
issn | 0835-7900 |
language | English |
publishDate | 2008-01-01 |
publisher | Wiley |
record_format | Article |
series | Canadian Journal of Gastroenterology |
spelling | doaj-art-3c6c7556d4464ce498ebe6998618e4c62025-02-03T01:22:13ZengWileyCanadian Journal of Gastroenterology0835-79002008-01-01221192393010.1155/2008/907356Clinical Manifestations of Hemochromatosis in HFE C282Y Homozygotes Identified by ScreeningGordon D McLaren0Christine E McLaren1Paul C Adams2James C Barton3David M Reboussin4Victor R Gordeuk5Ronald T Acton6Emily L Harris7Mark R Speechley8Phyliss Sholinsky9Fitzroy W Dawkins10Beverly M Snively11Thomas M Vogt12John H Eckfeldt13for the Hemochromatosis and Iron Overload Screening (HEIRS) Study Research InvestigatorsDepartment of Veterans Affairs Long Beach Healthcare System, Long Beach, and Division of Hematology/Oncology, Department of Medicine, University of California, Irvine, USAEpidemiology Division, Department of Medicine, University of California, Irvine, California, USADepartment of Medicine, London Health Sciences Centre, London, Ontario, CanadaSouthern Iron Disorders Center, Birmingham, Alabama, USADepartment of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USADepartment of Medicine, Howard University, Washington DC, USADepartments of Microbiology, Medicine, Genetics and Epidemiology and International Health, University of Alabama at Birmingham, Alabama, USAKaiser Permanente Center for Health Research, Portland, Oregon, current affiliation: Population Genomics, National Human Genome Research Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USADepartment of Epidemiology and Biostatistics, University of Western Ontario, London, Ontario, CanadaEpidemiology Branch, National Heart Lung and Blood Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USADepartment of Medicine, Howard University, Washington DC, USADepartment of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USAKaiser Permanente Center for Health Research, Honolulu, Hawaii, USADepartment of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, USABACKGROUND: Patients with hemochromatosis may suffer organ damage from iron overload, often with serious clinical consequences.http://dx.doi.org/10.1155/2008/907356 |
spellingShingle | Gordon D McLaren Christine E McLaren Paul C Adams James C Barton David M Reboussin Victor R Gordeuk Ronald T Acton Emily L Harris Mark R Speechley Phyliss Sholinsky Fitzroy W Dawkins Beverly M Snively Thomas M Vogt John H Eckfeldt for the Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators Clinical Manifestations of Hemochromatosis in HFE C282Y Homozygotes Identified by Screening Canadian Journal of Gastroenterology |
title | Clinical Manifestations of Hemochromatosis in HFE C282Y Homozygotes Identified by Screening |
title_full | Clinical Manifestations of Hemochromatosis in HFE C282Y Homozygotes Identified by Screening |
title_fullStr | Clinical Manifestations of Hemochromatosis in HFE C282Y Homozygotes Identified by Screening |
title_full_unstemmed | Clinical Manifestations of Hemochromatosis in HFE C282Y Homozygotes Identified by Screening |
title_short | Clinical Manifestations of Hemochromatosis in HFE C282Y Homozygotes Identified by Screening |
title_sort | clinical manifestations of hemochromatosis in hfe c282y homozygotes identified by screening |
url | http://dx.doi.org/10.1155/2008/907356 |
work_keys_str_mv | AT gordondmclaren clinicalmanifestationsofhemochromatosisinhfec282yhomozygotesidentifiedbyscreening AT christineemclaren clinicalmanifestationsofhemochromatosisinhfec282yhomozygotesidentifiedbyscreening AT paulcadams clinicalmanifestationsofhemochromatosisinhfec282yhomozygotesidentifiedbyscreening AT jamescbarton clinicalmanifestationsofhemochromatosisinhfec282yhomozygotesidentifiedbyscreening AT davidmreboussin clinicalmanifestationsofhemochromatosisinhfec282yhomozygotesidentifiedbyscreening AT victorrgordeuk clinicalmanifestationsofhemochromatosisinhfec282yhomozygotesidentifiedbyscreening AT ronaldtacton clinicalmanifestationsofhemochromatosisinhfec282yhomozygotesidentifiedbyscreening AT emilylharris clinicalmanifestationsofhemochromatosisinhfec282yhomozygotesidentifiedbyscreening AT markrspeechley clinicalmanifestationsofhemochromatosisinhfec282yhomozygotesidentifiedbyscreening AT phylisssholinsky clinicalmanifestationsofhemochromatosisinhfec282yhomozygotesidentifiedbyscreening AT fitzroywdawkins clinicalmanifestationsofhemochromatosisinhfec282yhomozygotesidentifiedbyscreening AT beverlymsnively clinicalmanifestationsofhemochromatosisinhfec282yhomozygotesidentifiedbyscreening AT thomasmvogt clinicalmanifestationsofhemochromatosisinhfec282yhomozygotesidentifiedbyscreening AT johnheckfeldt clinicalmanifestationsofhemochromatosisinhfec282yhomozygotesidentifiedbyscreening AT forthehemochromatosisandironoverloadscreeningheirsstudyresearchinvestigators clinicalmanifestationsofhemochromatosisinhfec282yhomozygotesidentifiedbyscreening |